Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-10 (N.D.W.Va. May. 6, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-10 (N.D.W.Va. May. 6, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-1 (N.D.W.Va. May. 6, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-1 (N.D.W.Va. May. 6, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-4 (N.D.W.Va. May. 6, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-4 (N.D.W.Va. May. 6, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-6 (N.D.W.Va. May. 6, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-6 (N.D.W.Va. May. 6, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-8 (N.D.W.Va. May. 6, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-8 (N.D.W.Va. May. 6, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-7 (N.D.W.Va. May. 6, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-7 (N.D.W.Va. May. 6, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-3 (N.D.W.Va. May. 6, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-3 (N.D.W.Va. May. 6, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-9 (N.D.W.Va. May. 6, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-9 (N.D.W.Va. May. 6, 2022)
+ More Snippets
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-5 (N.D.W.Va. May. 6, 2022)
Cite Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-5 (N.D.W.Va. May. 6, 2022)
+ More Snippets
Document
IPR2020-00324, No. 77 Motion - Joint Motion to Terminate as to Petitioner Pfizer (P.T.A.B. Jun. 18, 2021)
Cite Document
IPR2020-00324, No. 77 Motion - Joint Motion to Terminate as to Petitioner Pfizer (P.T.A.B. Jun. 18, 2021)
+ More Snippets
Document
IPR2020-00324, No. 78 Motion - Joint Request to Treat Settlement Agreement as Confidential (P.T.A.B. Jun. 18, 2021)
Cite Document
IPR2020-00324, No. 78 Motion - Joint Request to Treat Settlement Agreement as Confidential (P.T.A.B. Jun. 18, 2021)
+ More Snippets
Document
IPR2020-00324, No. 5 Corrected Petition - NOTICE ACCEPTING CORRECTED PETITION (P.T.A.B. Jan. 3, 2020)
Cite Document
IPR2020-00324, No. 5 Corrected Petition - NOTICE ACCEPTING CORRECTED PETITION (P.T.A.B. Jan. 3, 2020)
+ More Snippets
Document
IPR2020-00324, No. 5 Corrected Petition - NOTICE ACCEPTING CORRECTED PETITION (P.T.A.B. Jan. 3, 2020)
Cite Document
IPR2020-00324, No. 5 Corrected Petition - NOTICE ACCEPTING CORRECTED PETITION (P.T.A.B. Jan. 3, 2020)
+ More Snippets
Document
IPR2020-00324, No. 76 Motion - Pat Owners Unopposed Renewed Mot to Seal Exs 2023, 1078, 1079 (P.T.A.B. Jun. 11, 2021)
Cite Document
IPR2020-00324, No. 76 Motion - Pat Owners Unopposed Renewed Mot to Seal Exs 2023, 1078, 1079 (P.T.A.B. Jun. 11, 2021)
+ More Snippets
Document
IPR2020-00324, No. 3 Notice of Filing Date Accorded to Petition - Notice of Accord Filing Date (P.T.A.B. Dec. 30, 2019)
Cite Document
IPR2020-00324, No. 3 Notice of Filing Date Accorded to Petition - Notice of Accord Filing Date (P.T.A.B. Dec. 30, 2019)
+ More Snippets